The South Korean office of the Danish pharmaceutical company Novo Nordisk recently requested the local authorities to permit ...

Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...

‘The face has a layer of fat that essentially stretches the skin. Ozempic results in rapid weight loss and does so very ...

A new oral weight loss pill shows results similar to Ozempic and Wegovy injections in the treatment of obesity.

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

AROUND half a million Brits use weight loss drugs. And that number is expected to double in the next year with the rise in ...

Weight loss drugs can cause side effects including nausea, vomiting, diarrhoea, haemorrhoids and constipation, which can ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

Clinical trials have shown that Wegovy can lead to an average weight loss of 15-18% over 68 weeks. It is approved for use in individuals with a BMI of 30 or greater or those with a BMI of 27 or ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes.

In Australia, Ozempic is approved for the treatment of type 2 diabetes, while Wegovy is approved for weight management. Both ...